VIDEO: Vevye improves Schirmer’s scores by 98%

ATLANTA — A long-term study of Vevye for treating dry eye showed an improvement in Schirmer’s scores by 98% at week 46, according to Walter O. Whitley, OD, MBA, FAAO.
Harrow’s Vevye contains cyclosporine 0.1%, with perfluorobutylpentane as the carrier, allowing it “to get into the tissue and render its effect,” Whitley, director of optometric services at Virginia Eye Consultants in Norfolk, said in this Healio video.
The 98% increase in Schirmer’s score at 46 weeks is important because, “we know that with Schirmer’s, we’re improving the tear,”

ATLANTA — A long-term study of Vevye for treating dry eye showed an improvement in Schirmer’s scores by 98% at week 46, according to Walter O. Whitley, OD, MBA, FAAO.
Harrow’s Vevye contains cyclosporine 0.1%, with perfluorobutylpentane as the carrier, allowing it “to get into the tissue and render its effect,” Whitley, director of optometric services at Virginia Eye Consultants in Norfolk, said in this Healio video.
The 98% increase in Schirmer’s score at 46 weeks is important because, “we know that with Schirmer’s, we’re improving the tear,”